Collegium Pharmaceutical COLL
NASDAQ COLL
$22.22 +0.40 (+1.81%)
As of: Oct 1, 2026 · 3:01 PM EDT

Collegium Pharmaceutical (COLL) Non Operating Interest Expenses (2015 - 2026)

Updated

Collegium Pharmaceutical's Non Operating Interest Expenses was $19.52 million in Q2 2026, down 4.6% from $20.46 million a year earlier but up 23.1% from the prior quarter.

Analysis

Collegium Pharmaceutical (COLL) Non Operating Interest Expenses (2015 - 2026) Analysis & Trends

On a trailing twelve-month basis, Collegium Pharmaceutical's Non Operating Interest Expenses was $76.44 million through Jun 30, 2026, down 7.1% year-over-year; for FY2025, it was $82.31 million, up 11.3% from FY2024.

  • Non Operating Interest Expenses shows a five-year compound annual growth rate of 23.3% (FY2020 to FY2025).
  • In earlier years, Non Operating Interest Expenses was $73.97 million in FY2024 (-11.2%), $83.34 million in FY2023 (+31.8%), $63.21 million in FY2022 (+200.8%) and $21.01 million in FY2021 (-27.2%).
  • Quarterly Non Operating Interest Expenses has moved between $4.76 million (Q4 2021) and $22.65 million (Q4 2024) over five years.
  • Compared with a year earlier, Non Operating Interest Expenses has declined for three straight quarters, with growth averaging 4.1% over the last eight quarters.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was Q4 2022 (growth of 332.5%); the worst was Q4 2021 (a decline of 38.5%).
  • Per Business Quant data, COLL's Non Operating Interest Expenses in the three quarters before Q2 2026 was $15.86 million (Q1 2026), $19.29 million (Q4 2025) and $21.77 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Collegium Pharmaceutical 709.11 Mn -514.65 Mn 110.29 Mn 19.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.52 Mn
Mar 31, 2026 15.86 Mn
Dec 31, 2025 19.29 Mn
Sep 30, 2025 21.77 Mn
Jun 30, 2025 20.46 Mn
Mar 31, 2025 20.79 Mn
Dec 31, 2024 22.65 Mn
Sep 30, 2024 18.39 Mn
Jun 30, 2024 15.59 Mn
Mar 31, 2024 17.34 Mn
Dec 31, 2023 19.28 Mn
Sep 30, 2023 20.77 Mn
Jun 30, 2023 21.86 Mn
Mar 31, 2023 21.43 Mn
Dec 31, 2022 20.58 Mn
Sep 30, 2022 19.05 Mn
Jun 30, 2022 17.76 Mn
Mar 31, 2022 5.83 Mn
Dec 31, 2021 4.76 Mn
Sep 30, 2021 5.12 Mn
API Access

Collegium Pharmaceutical Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=COLL&period=max&api_key=YOUR_API_KEY